Stay updated on Cabozantinib and Durvalumab Immuno-oncology Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib and Durvalumab Immuno-oncology Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib and Durvalumab Immuno-oncology Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    A notice about NIH website changes appears above the 403 error page, and the site revision label changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T23:06:19.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changes from v3.7.0 to v3.7.1; the page otherwise remains a 403 Forbidden error page.
    Difference
    0.2%
    Check dated 2026-10-07T00:24:26.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The study page now returns a 403 Forbidden error, replacing the previously visible trial details with an access-denied message. This blocks access to core information about the trial, including its status, eligibility, locations, and contacts.
    Difference
    20%
    Check dated 2026-09-22T23:21:18.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page revision has been upgraded from v3.6.6 to v3.7.0, indicating a new version of the page. This update likely includes minor adjustments to layout or content without changing the core study information.
    Difference
    0.1%
    Check dated 2026-09-15T22:12:47.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.6, replacing Revision: v3.6.5, indicating a minor version update to the page’s template or underlying platform.
    Difference
    0.1%
    Check dated 2026-09-01T19:39:22.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    The page revision was updated to v3.6.5, signaling a minor update to the page. This change represents a backend or UI update rather than a modification to study details.
    Difference
    0.1%
    Check dated 2026-08-11T16:22:52.000Z thumbnail image

Stay in the know with updates to Cabozantinib and Durvalumab Immuno-oncology Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Durvalumab Immuno-oncology Clinical Trial page.